跳转至内容
Merck
CN
所有图片(1)

文件

AB2080

Sigma-Aldrich

抗-CD44v6抗体(外显子v6)

Chemicon®, from rabbit

登录查看公司和协议定价

别名:
Anti-CDW44, Anti-ECMR-III, Anti-HCELL, Anti-HUTCH-I, Anti-IN, Anti-LHR, Anti-MC56, Anti-MDU2, Anti-MDU3, Anti-MIC4, Anti-Pgp1
UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

rabbit

质量水平

抗体形式

purified immunoglobulin

抗体产品类型

primary antibodies

克隆

polyclonal

种属反应性

human, canine, mouse, bovine, pig, rabbit

制造商/商品名称

Chemicon®

技术

ELISA: suitable
flow cytometry: suitable
immunocytochemistry: suitable
immunohistochemistry: suitable (paraffin)
immunoprecipitation (IP): suitable
western blot: suitable

UniProt登记号

运输

wet ice

靶向翻译后修饰

unmodified

基因信息

human ... CD44(960)

特异性

CD44v6(大约200/-250 kDa)

免疫原

人 CD44v6的合成肽
表位:外显子v6

应用

ELISA:1:1000-1:2000

流式细胞术:1:500-1:1,000.

免疫荧光: 1:100-1:200

石蜡包埋组织的免疫组织化学染色:1:150-1:250

免疫沉淀:1:100-1:200

蛋白质印迹 1:5000-1:10,000

RIA: 1:5,000

最佳工作稀释度必须由最终用户进行确定。
抗-CD44v6抗体(外显子v6)是针对CD44v6的抗体,用于ELISA、FC、IP、WB、IC、IH(P)。
研究子类别
粘附(CAMs)
研究类别
细胞结构

联系

替代:04-1123

外形

形式:纯化
纯化 IgG。 溶于含150 mM NaCl和0.01%叠氮化钠的10 mM磷酸盐缓冲液(pH 7.5)中的液体。

储存及稳定性

自接收之日起,以未稀释的等分试样在2-8°C下保存长达12个月。

其他说明

浓度:请参考批次特异性浓缩物的检验报告。

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sureerat Padthaisong et al.
Journal of translational medicine, 18(1), 64-64 (2020-02-11)
Cancer recurrence is the important problem of cholangiocarcinoma (CCA) patients, lead to a very high mortality rate. Therefore, the identification of candidate markers to predict CCA recurrence is needed in order to effectively manage the disease. This study aims to
Yulian Wang et al.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 8(13), 2004929-2004929 (2021-07-15)
The blood-brain barrier (BBB) is the most restrictive and complicated barrier that keeps most biomolecules and drugs from the brain. An efficient brain delivery strategy is urgently needed for the treatment of brain diseases. Based on the studies of brain-targeting
Ayse Sahaboglu et al.
Scientific reports, 6, 39537-39537 (2016-12-23)
The enzyme poly-ADP-ribose-polymerase (PARP) mediates DNA-repair and rearrangements of the nuclear chromatin. Generally, PARP activity is thought to promote cell survival and in recent years a number of PARP inhibitors have been clinically developed for cancer treatment. Paradoxically, PARP activity
X Yuan et al.
Oncogenesis, 5(11), e268-e268 (2016-11-08)
The stem cell factor SALL4 (Sal-like protein 4) plays important roles in the development and progression of cancer. SALL4 is critically involved in tumour growth, metastasis and therapy resistance. However, the underlying mechanisms responsible for the oncogenic roles of SALL4
Martina Lepore Signorile et al.
Cell death & disease, 12(4), 316-316 (2021-03-27)
The prognosis of locally advanced colorectal cancer (CRC) is currently unsatisfactory. This is mainly due to drug resistance, recurrence, and subsequent metastatic dissemination, which are sustained by the cancer stem cell (CSC) population. The main driver of the CSC gene

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门